Purdue Pharma, manufacturer of OxyContin, is set to dissolve and transform into a public-benefit company by week's end following judicial approval of its criminal sentence. This development signals a significant shift in corporate responsibility within pharmaceuticals, impacting how tech professionals approach ethical considerations in health technology. The next step will likely involve monitoring the new entity’s efforts to address the opioid crisis.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
2
Ali NematiWritten by Ali
![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)
